XWELL PE Ratio 2011-2025 | XWEL
Current and historical p/e ratio for XWELL (XWEL) from 2011 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. XWELL PE ratio as of November 07, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| XWELL PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-11-07 | 0.84 | 0.00 | |
| 2025-06-30 | 0.92 | $-4.10 | 0.00 |
| 2025-03-31 | 1.02 | $-4.02 | 0.00 |
| 2024-12-31 | 1.51 | $-3.62 | 0.00 |
| 2024-09-30 | 1.73 | $-3.64 | 0.00 |
| 2024-06-30 | 1.80 | $-5.03 | 0.00 |
| 2024-03-31 | 1.69 | $-5.95 | 0.00 |
| 2023-12-31 | 1.74 | $-6.75 | 0.00 |
| 2023-09-30 | 2.25 | $-8.18 | 0.00 |
| 2023-06-30 | 4.00 | $-7.40 | 0.00 |
| 2023-03-31 | 7.20 | $-7.60 | 0.00 |
| 2022-12-31 | 7.20 | $-7.00 | 0.00 |
| 2022-09-30 | 15.40 | $-3.40 | 0.00 |
| 2022-06-30 | 13.80 | $-0.80 | 0.00 |
| 2022-03-31 | 22.60 | $0.00 | 0.00 |
| 2021-12-31 | 40.40 | $0.60 | 67.33 |
| 2021-09-30 | 29.40 | 0 | 0.00 |
| 2021-06-30 | 30.80 | $-3.00 | 0.00 |
| 2021-03-31 | 36.80 | $-32.40 | 0.00 |
| 2020-12-31 | 23.80 | $-67.00 | 0.00 |
| 2020-09-30 | 39.40 | $-67.00 | 0.00 |
| 2020-06-30 | 83.80 | $-165.81 | 0.00 |
| 2020-03-31 | 11.40 | $-328.83 | 0.00 |
| 2019-12-31 | 40.20 | $-390.64 | 0.00 |
| 2019-09-30 | 86.40 | $-390.64 | 0.00 |
| 2019-06-30 | 116.40 | $-421.84 | 0.00 |
| 2019-03-31 | 144.00 | $-384.64 | 0.00 |
| 2018-12-31 | 192.00 | $-1,368.14 | 0.00 |
| 2018-09-30 | 180.00 | $-1,368.14 | 0.00 |
| 2018-06-30 | 348.00 | $-1,476.15 | 0.00 |
| 2018-03-31 | 864.00 | $-1,752.18 | 0.00 |
| 2017-12-31 | 1644.00 | $-1,080.11 | 0.00 |
| 2017-09-30 | 1668.00 | $-1,368.14 | 0.00 |
| 2017-06-30 | 1980.00 | $-1,536.15 | 0.00 |
| 2017-03-31 | 2604.00 | $-1,968.20 | 0.00 |
| 2016-12-31 | 2556.00 | $-1,896.19 | 0.00 |
| 2016-09-30 | 3228.00 | $-1,608.16 | 0.00 |
| 2016-06-30 | 2268.00 | $-2,640.26 | 0.00 |
| 2016-03-31 | 1968.00 | $-2,856.29 | 0.00 |
| 2015-12-31 | 2964.00 | $-3,360.34 | 0.00 |
| 2015-09-30 | 6720.00 | $-13,201.32 | 0.00 |
| 2015-06-30 | 6720.00 | $-13,681.37 | 0.00 |
| 2015-03-31 | 7800.00 | $-13,921.39 | 0.00 |
| 2014-12-31 | 6600.00 | $-14,641.46 | 0.00 |
| 2014-09-30 | 11400.00 | $-4,800.48 | 0.00 |
| 2014-06-30 | 41040.00 | $-4,440.44 | 0.00 |
| 2014-03-31 | 41640.00 | $-4,680.47 | 0.00 |
| 2013-12-31 | 35520.00 | $-4,920.49 | 0.00 |
| 2013-09-30 | 34440.00 | $-7,440.74 | 0.00 |
| 2013-06-30 | 38040.00 | $-8,040.80 | 0.00 |
| 2013-03-31 | 38040.00 | $-10,801.08 | 0.00 |
| 2012-12-31 | 34440.00 | $-14,521.45 | 0.00 |
| 2012-09-30 | 34800.00 | $-12,001.20 | 0.00 |
| 2012-06-30 | 46320.00 | $-13,681.37 | 0.00 |
| 2012-03-31 | 19800.00 | $-12,481.25 | 0.00 |
| 2011-12-31 | 11880.00 | $-9,240.92 | 0.00 |
| 2011-09-30 | 17040.00 | $-9,240.92 | 0.00 |
| 2011-06-30 | 14640.00 | $-11,401.14 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.005B | $0.034B |
| XWELL Inc. is a health and wellness holding company. Its operating brands include XpresCheck(R), XpresSpa(R), Treat(TM) and HyperPointe. XpresSpa is a retailer of wellness services and related products. Treat is a travel health and wellness brand. XpresCheck is a provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo. HyperPointe is a digital healthcare and data analytics relationship company. XWELL Inc., formerly known as XpresSpa Group Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.807B | 27.32 |
| HCA Healthcare (HCA) | United States | $107.561B | 17.81 |
| CVS Health (CVS) | United States | $99.854B | 11.48 |
| Elevance Health (ELV) | United States | $69.881B | 10.25 |
| Cencora (COR) | United States | $69.843B | 22.53 |
| Natera (NTRA) | United States | $27.241B | 0.00 |
| DiDi Global (DIDIY) | China | $24.615B | 20.11 |
| Labcorp Holdings (LH) | United States | $20.446B | 15.59 |
| Medpace Holdings (MEDP) | United States | $16.681B | 41.41 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.398B | 0.00 |
| ICON (ICLR) | Ireland | $12.921B | 12.82 |
| CochLear (CHEOY) | Australia | $12.049B | 0.00 |
| Viatris (VTRS) | United States | $11.672B | 4.34 |
| Solventum (SOLV) | United States | $11.492B | 11.16 |
| Revvity (RVTY) | United States | $10.149B | 18.69 |
| Charles River Laboratories (CRL) | United States | $8.410B | 16.20 |
| HealthEquity (HQY) | United States | $7.990B | 31.98 |
| Avantor (AVTR) | United States | $7.718B | 11.79 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.944B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.618B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $5.879B | 35.05 |
| Bausch + Lomb (BLCO) | Canada | $5.501B | 36.12 |
| Sotera Health (SHC) | United States | $4.548B | 21.93 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 23.68 |
| GeneDx Holdings (WGS) | United States | $3.984B | 70.41 |
| Alignment Healthcare (ALHC) | United States | $3.300B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.771B | 34.85 |
| Concentras Parent (CON) | United States | $2.398B | 14.97 |
| Premier (PINC) | United States | $2.323B | 22.51 |
| Ardent Health (ARDT) | United States | $2.069B | 7.99 |
| PACS (PACS) | United States | $1.902B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.880B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.874B | 11.19 |
| Organon (OGN) | United States | $1.744B | 1.90 |
| Progyny (PGNY) | United States | $1.549B | 30.52 |
| Teladoc Health (TDOC) | United States | $1.352B | 0.00 |
| Omada Health (OMDA) | $1.259B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.098B | 17.56 |
| Embecta (EMBC) | United States | $0.787B | 4.61 |
| CareDx (CDNA) | United States | $0.772B | 12.61 |
| AMN Healthcare Services Inc (AMN) | United States | $0.706B | 9.75 |
| Nutex Health (NUTX) | United States | $0.676B | 10.24 |
| InnovAge Holding (INNV) | United States | $0.662B | 0.00 |
| Pomdoctor - (POM) | China | $0.616B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.587B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.536B | 0.00 |
| So-Young (SY) | China | $0.434B | 0.00 |
| CryoPort (CYRX) | United States | $0.417B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.409B | 6.14 |
| Enhabit (EHAB) | United States | $0.390B | 17.52 |
| Strata Critical Medical (SRTA) | United States | $0.380B | 0.00 |
| Oncology Institute (TOI) | United States | $0.356B | 0.00 |
| Charming Medical (MCTA) | $0.350B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.320B | 7.00 |
| KindlyMD (NAKA) | United States | $0.320B | 0.00 |
| Agilon Health (AGL) | United States | $0.289B | 0.00 |
| LifeMD (LFMD) | United States | $0.249B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.228B | 0.00 |
| Beauty Health (SKIN) | United States | $0.164B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.146B | 24.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.112B | 0.00 |
| DocGo (DCGO) | United States | $0.105B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.048B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.028B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 5.78 |
| Co-Diagnostics (CODX) | United States | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.016B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.015B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |